ID: ALA448551

Max Phase: Preclinical

Molecular Formula: C31H39FN3O14P3

Molecular Weight: 789.58

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c(N2CCN(C(=O)CC(C)(C)c3cc(P(=O)(O)CP(=O)(O)O)ccc3OP(=O)(O)O)C(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12

Standard InChI:  InChI=1S/C31H39FN3O14P3/c1-17-14-33(27-23(32)12-20-26(29(27)48-4)35(18-5-6-18)15-21(28(20)37)30(38)39)9-10-34(17)25(36)13-31(2,3)22-11-19(50(40,41)16-51(42,43)44)7-8-24(22)49-52(45,46)47/h7-8,11-12,15,17-18H,5-6,9-10,13-14,16H2,1-4H3,(H,38,39)(H,40,41)(H2,42,43,44)(H2,45,46,47)

Standard InChI Key:  UZFDLFVNHZEZJR-UHFFFAOYSA-N

Associated Targets(Human)

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bone 37 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serum 604 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 789.58Molecular Weight (Monoisotopic): 789.1629AlogP: 3.09#Rotatable Bonds: 12
Polar Surface Area: 253.67Molecular Species: ACIDHBA: 10HBD: 6
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: -4.49CX Basic pKa: CX LogP: 0.83CX LogD: -8.35
Aromatic Rings: 3Heavy Atoms: 52QED Weighted: 0.14Np Likeness Score: -0.27

References

1. Houghton TJ, Tanaka KS, Kang T, Dietrich E, Lafontaine Y, Delorme D, Ferreira SS, Viens F, Arhin FF, Sarmiento I, Lehoux D, Fadhil I, Laquerre K, Liu J, Ostiguy V, Poirier H, Moeck G, Parr TR, Far AR..  (2008)  Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis.,  51  (21): [PMID:18834106] [10.1021/jm801007z]

Source